Cullinan Oncology Statistics

Total Valuation

CGEM has a market cap or net worth of $940.01 million. The enterprise value is $510.17 million.

Market Cap	940.01M
Enterprise Value	510.17M

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, before market open.

Earnings Date	Aug 8, 2024
Ex-Dividend Date	n/a

Share Statistics

CGEM has 57.63 million shares outstanding. The number of shares has increased by 5.72% in one year.

Shares Outstanding	57.63M
Shares Change (YoY)	+5.72%
Shares Change (QoQ)	+0.47%
Owned by Insiders (%)	4.54%
Owned by Institutions (%)	78.80%
Float	37.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	6.30
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.21
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 20.33, with a Debt / Equity ratio of 0.01.

Current Ratio	20.33
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -28.70% and return on invested capital (ROIC) is -39.95%.

Return on Equity (ROE)	-28.70%
Return on Assets (ROA)	-27.10%
Return on Capital (ROIC)	-39.95%
Revenue Per Employee	n/a
Profits Per Employee	-$1.56M
Employee Count	85
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-14.12M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +52.43% in the last 52 weeks. The beta is -0.06, so CGEM's price volatility has been lower than the market average.

Beta (5Y)	-0.06
52-Week Price Change	+52.43%
50-Day Moving Average	22.37
200-Day Moving Average	14.91
Relative Strength Index (RSI)	31.27
Average Volume (20 Days)	1,080,269

Short Selling Information

The latest short interest is 4.52 million, so 7.84% of the outstanding shares have been sold short.

Short Interest	4.52M
Short Previous Month	4.34M
Short % of Shares Out	7.84%
Short % of Float	12.04%
Short Ratio (days to cover)	6.63

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-171.32M
Pretax Income	-146.47M
Net Income	-132.35M
EBITDA	-146.16M
EBIT	-146.47M
Earnings Per Share (EPS)	-$3.13

Full Income Statement

Balance Sheet

The company has $433.01 million in cash and $3.17 million in debt, giving a net cash position of $429.84 million or $7.46 per share.

Cash & Cash Equivalents	433.01M
Total Debt	3.17M
Net Cash	429.84M
Net Cash Per Share	$7.46
Equity (Book Value)	425.67M
Book Value Per Share	7.39
Working Capital	423.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$121.53 million and capital expenditures -$49,000, giving a free cash flow of -$121.57 million.

Operating Cash Flow	-121.53M
Capital Expenditures	-49,000
Free Cash Flow	-121.57M
FCF Per Share	-$2.83

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CGEM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.72%
Shareholder Yield	-5.72%
Earnings Yield	-14.08%
FCF Yield	-12.93%

Analyst Forecast

The average price target for CGEM is $32.00, which is 96.20% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$32.00
Price Target Difference	96.20%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-4.13%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3